@article{ref1,
title="Argyreia nervosa exposures reported to Texas poison centers",
journal="Journal of addictive diseases",
year="2019",
author="Forrester, Mathias B.",
volume="ePub",
number="ePub",
pages="1-5",
abstract="The seeds of <i>Argyreia nervosa</i> (Hawaiian baby woodrose) contain lysergamide or lysergic acid amine, an analog for lysergic acid diethylamide. Twenty-nine <i>Argyreia nervosa</i> exposures reported to Texas poison centers during 2000-2018 were identified. Seventy-nine percent of the patients were male; the mean age was 24 years (range 16-53 years). The exposure route was 97% ingestion and 3% inhalation. Ninety-three percent of the exposures occurred at the patient's own residence and 3% at another residence. Fourteen percent of the patients were managed on-site, 69% were already at or en route to a healthcare facility when the poison center was contacted, and 17% were referred to a healthcare facility by the poison center. The medical outcome was 3% no effect, 31% minor effect, 38% moderate effect, 7% major effect, 7% not followed-minimal clinical effects possible, and 14% unable to follow-potentially toxic. The most frequent clinical effects were gastrointestinal (45%) and neurological (41%). The most frequently reported treatments were administration of intravenous fluids (28%) and benzodiazepines (21%).<p /> <p>Language: en</p>",
language="en",
issn="1055-0887",
doi="10.1080/10550887.2019.1640057",
url="http://dx.doi.org/10.1080/10550887.2019.1640057"
}